Leishmania cell membrane and ribosomal protein synthesis — Drug Target

All drugs that target Leishmania cell membrane and ribosomal protein synthesis — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Antiparasitic combination therapy · Antiparasitic combination

Phase 3 pipeline (2)

• miltefosine + Paromomycin sulfate · Banaras Hindu University · Antiparasitic combination therapy · Infectious Disease / Parasitology
  Miltefosine disrupts parasite cell membranes while paromomycin inhibits protein synthesis, together providing synergistic activity against Leishmania parasites.
• Miltefosine and Paromomycin · Drugs for Neglected Diseases · Antiparasitic combination · Infectious Disease / Neglected Tropical Diseases
  Miltefosine disrupts parasite cell membranes while paromomycin inhibits protein synthesis, together providing synergistic activity against Leishmania parasites.